Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Harland

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Genes, Chromosomes & Cancer|March 12, 2005
Intronic sequence variants of the CDKN2A gene in melanoma pedigreesMark Harland, Claire F Taylor, Sylvia Bass, et al.
Molecular and Cellular Biology|November 6, 2002
Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblastsThomas J Huot, Janice Rowe, Mark Harland, et al.
Melanoma Research|May 17, 2007
CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based populationDace Pjanova, Ludmila Engele, Juliette A Randerson-Moor, et al.
Melanoma Research|November 6, 2020
Sentinel node biopsy in cutaneous melanoma patients with germline CDKN2A mutationsNorbertus A Ipenburg, Jos A van der Hage, Julia A Newton-Bishop, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 1, 2024
APOE genotype, eicosapentaenoic acid (EPA) supplementation and n-3 highly unsaturated fatty acid (HUFA) levels in patients with multiple colorectal polyps: A secondary analysis of the seAFOod polyp prevention trialGe Sun, John R Davies, Tracey Mell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 5, 2025
Paradoxical Activation of Entheseal Myeloid Cells by JAK1 and TYK2 Inhibitors via IL10 AntagonismSami Giryes, Chi Wong, Charlie Bridgewood, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
No Evidence for BRAF as a melanoma/nevus susceptibility geneSharon Jackson, Mark Harland, Faye Turner, et al.
Genes, Chromosomes & Cancer|July 21, 2005
Prevalence of 9p21 deletions in UK melanoma familiesSushila H Mistry, Claire Taylor, Juliette A Randerson-Moor, et al.
JNCI Cancer Spectrum|October 21, 2022
Impact of Transcript (p16/p14ARF) Alteration on Cancer Risk in CDKN2A Germline Pathogenic Variant CarriersMichael R Sargen, Hildur Helgadottir, Xiaohong R Yang, et al.
The Journal of Investigative Dermatology|April 7, 2024
Systemic Inflammation, the Peripheral Blood Transcriptome, and Primary MelanomaJuliette Randerson-Moor, John Davies, Mark Harland, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Genes, Chromosomes & Cancer|March 12, 2005
Intronic sequence variants of the CDKN2A gene in melanoma pedigreesMark Harland, Claire F Taylor, Sylvia Bass, et al.
Molecular and Cellular Biology|November 6, 2002
Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblastsThomas J Huot, Janice Rowe, Mark Harland, et al.
Melanoma Research|May 17, 2007
CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based populationDace Pjanova, Ludmila Engele, Juliette A Randerson-Moor, et al.
Melanoma Research|November 6, 2020
Sentinel node biopsy in cutaneous melanoma patients with germline CDKN2A mutationsNorbertus A Ipenburg, Jos A van der Hage, Julia A Newton-Bishop, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 1, 2024
APOE genotype, eicosapentaenoic acid (EPA) supplementation and n-3 highly unsaturated fatty acid (HUFA) levels in patients with multiple colorectal polyps: A secondary analysis of the seAFOod polyp prevention trialGe Sun, John R Davies, Tracey Mell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 5, 2025
Paradoxical Activation of Entheseal Myeloid Cells by JAK1 and TYK2 Inhibitors via IL10 AntagonismSami Giryes, Chi Wong, Charlie Bridgewood, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
No Evidence for BRAF as a melanoma/nevus susceptibility geneSharon Jackson, Mark Harland, Faye Turner, et al.
Genes, Chromosomes & Cancer|July 21, 2005
Prevalence of 9p21 deletions in UK melanoma familiesSushila H Mistry, Claire Taylor, Juliette A Randerson-Moor, et al.
JNCI Cancer Spectrum|October 21, 2022
Impact of Transcript (p16/p14ARF) Alteration on Cancer Risk in CDKN2A Germline Pathogenic Variant CarriersMichael R Sargen, Hildur Helgadottir, Xiaohong R Yang, et al.
The Journal of Investigative Dermatology|April 7, 2024
Systemic Inflammation, the Peripheral Blood Transcriptome, and Primary MelanomaJuliette Randerson-Moor, John Davies, Mark Harland, et al.
Pageof 8